# US 2005/0233335 A1 · Nucleic and melting analysis with saturation dyes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0233335 A1
- Document ID: US20050233335A1
- Status: Published application
- Kind: A1
- Application number: 10/827,890
- Filed: 2004-04-20
- Published: 2005-10-20
- Earliest claimed: 2004-04-20
- Assignees: University of Utah Research Foundation; Idaho Technology, Inc.
- Inventors: Carl Wittwer; Luming Zhou; Virginie Dujols; Joseph Holden; Carlynn Willmore-Payne
- Web page: https://patentgrep.com/patent/US20050233335A1

## CPC

- C12Q 1/6851: Quantitative amplification
- C09B 23/04: one >CH- group, e.g. cyanines, isocyanines, pseudocyanines
- C12Q 1/6813: Hybridisation assays
- Y10S 435/975: Kit
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Methods are provided for nucleic acid analysis wherein a target nucleic acid is mixed with a dsDNA binding dye to form a mixture. Optionally, an unlabeled probe is included in the mixture. A melting curve is generated for the target nucleic acid by measuring fluorescence from the dsDNA binding dye as the mixture is heated. Dyes for use in nucleic acid analysis and methods for making dyes are also provided.

## Claims

### Claim 1

A compound having the formula:
wherein
the moiety
represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;
X is oxygen, sulfur, selenium, tellurium or a-moiety selected from C(CH3)2 and NR1, where R1 is hydrogen or C1-6 alkyl;
R2 is selected from the group consisting of C1-6 alkyl, C3-8 cycloalkyl, aryl, aryl(C1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;
t=0 or 1;
Z is a charge selected from 0 or 1;
R3, R9, and R10 are each independently selected from the group consisting of hydrogen, C1-6 alkyl, and arylcarbonyl;
n=0, 1, or 2; and
Q is an heterocycle selected from the group of structures consisting of:
wherein R4, R5, R6, R7, and R8 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, dialkylamino, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety, a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

### Claim 2 (depends on 1)

The compound of claim 1, wherein at least one of R4, R5, R6, R7, and R8 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.

### Claim 3 (depends on 2)

The compound of claim 2, wherein R4 is optionally substituted arylcarbonylthio and is selected from the group consisting of 4-(carbonylthio)-pyridinyl, 4-(carbonylthio)-nitrophenyl, 4-(carbonylthio)-phenyl, 4-(carbonylthio)-N,N-dimethylanilinyl, 2-(carbonylthio)-pyrazinyl, 6-(carbonylthio)-benzopyrazinyl, 5-(carbonylthio)-1-methyl-1,2,3-benzotriazolyl, and carbonylthio-pentafluorophenyl.

### Claim 4 (depends on 2)

The compound of claim 2, wherein R4 is optionally substituted cycloheteroalkylcarbonylthio and is selected from the group consisting of 4-(carbonylthio)-N-methylpiperazinyl and 4-(carbonylthio)-morpholinyl.

### Claim 5 (depends on 2)

The compound of claim 2, wherein R4 is the optionally substituted dialkylaminoalkylcarbonylthio group N,N-dimethylaminomethylcarbonylthio.

### Claim 6 (depends on 2)

The compound of claim 2, wherein R4 is the optionally substituted cycloalkylthio group 1-(thio)-bicyclo[2.2.1]heptyl.

### Claim 7 (depends on 2)

The compound of claim 2, wherein R4 is the optionally substituted cycloheteroalkylthio group 4-(thio)-N-methylpiperadinyl.

### Claim 8 (depends on 2)

The compound of claim 2, wherein R4 is the optionally substituted trialkylammoniumalkylthio group trimethylammoniumpropylthio.

### Claim 9 (depends on 2)

The compound of claim 2, wherein R4 is the optionally substituted nucleosidylthio group 5′-deoxy-adenosinyl-thio.

### Claim 10 (depends on 2)

The compound of claim 2, having the formula:

### Claim 11 (depends on 1)

The compound of claim 1, wherein at least one of R4, R5, R6, R7, and R8 is selected from the group consisting of 4-(carbonylthio)-pyridinyl, 4-(carbonylthio)-nitrophenyl, 4-(carbonylthio)-phenyl, 4-(carbonylthio)-N,N-dimethylanilinyl, 2-(carbonylthio)-pyrazinyl, 6-(carbonylthio)-benzopyrazinyl, 5-(carbonylthio)- 1-methyl- 1,2,3-benzotriazolyl, carbonylthio-pentafluorophenyl, 4-(carbonylthio)-N-methylpiperazinyl, 4-(carbonylthio)-morpholinyl, N,N-dimethylaminomethylcarbonylthio, 1-(thio)-bicyclo [2.2.1]heptyl, 4-(thio)-N-methylpiperadinyl, trimethylammoniumpropylthio, and 5′-deoxy-adenosinyl-thio.

### Claim 12 (depends on 1)

The compound of claim 1, with the proviso that at least one of R4, R5, R6, R7, and R8 is not selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, and dialkylamino, each of which may be optionally substituted; trimethylammoniumpropyl; methylthio; amino; hydroxyl; N,N-dimethylpiperazinyl; pyrimidinylthio; a BRIDGE DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

### Claim 13 (depends on 1)

The compound of claim 1, with the proviso that R4, R5, R6, and R7 are not selected from the group consisting of halogen, cycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, alkoxy, and dialkylamino, each of which may be optionally substituted; a BRIDGE DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

### Claim 14 (depends on 1)

The compound of claim 1, with the proviso that R4 is not selected from the group consisting hydrogen, N,N-dimethylpiperazinyl, pyrimidinylthio, methylthio, thiol, amino, and hydroxyl.

### Claim 15 (depends on 1)

The compound of claim 1, with the proviso that R5is not selected from the group consisting of trimethylammoniumpropyl and phenyl.

### Claim 16 (depends on 1)

The compound of claim 1, with the proviso that R6 is not selected from the group consisting of hydrogen, methyl, and phenyl.

### Claim 17 (depends on 1)

The compound of claim 1, with the proviso that R7 is not hydrogen.

### Claim 18 (depends on 1)

The compound of claim 1, with the proviso that the compound is not selected from the group consisting of G5, H5, I5, K5, L5, D6, E6, P6, R6, Y6, Z6, F7, C8, E8, G8, L8, M8, N8, O8, and V8.

### Claim 19 (depends on 1)

The compound of claim 1, wherein the compound is selected from the group consisting of N7, O7, P7, Q7, R7, S7, T7, U7, V7, W7, X7, Z7, K8, P8, T8, W8, X8, Z8, A9, C9, G9,I9, J9, K9, L9, M9, N9, O9, P9, Q9, R9, and A10.

### Claim 20

A process for preparing a dye having the formula:
the process comprising the step of reacting a compound having the formula:
with a compound having the formula:
wherein:
the moiety Y represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing ring;
A is hydrogen, or A represents one or more substituents each independently selected from the group consisting of alkyl, halo, amino, haloalkyl, alkoxy, haloalkoxy, alkylsulfonyl, haloalkylsulfonyl, arylsulfonyl, alkylthio, arylthio, formyl, alkylcarbonyl, arylcarbonyl, carboxylic acid derivatives, monoalkylamino, dialkylamino, trialkylammonium, dialkylaminoalkyl, trialkylammoniumalkyl, piperidino, piperazino, each of which may be optionally substituted with alkyl, amino, mono or dialkylaminoalkyl, trialkylammoniumalkyl, or may be optionally quaternized on the nitrogen with an alkyl group;
t=0 or 1;
Z is a charge selected from 0 or 1;
X is oxygen or sulfur;
L is a leaving group;
R2 is selected from the group consisting of C1-6 alkyl, C2-6 alkyl, C3-8 cycloalkyl, aryl, aryl(C1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, trialkylammoniumalkyl, alkylcarbonyl, arylcarbonyl, alkylsulfonyl, arylsulfonyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, and alkylenesulfonic acid;
R4 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.
R5 is selected from the group consisting of C1-6 alkyl, C2-6 alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, monoalkylamino, dialkylamino, trialkylammonium, dialkylaminoalkyl, and trialkylammoniumalkyl, aryl, heteroaryl, each of which may be optionally substituted; and
R6 and R8 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, arylthio, arylcarbonylthio, dialkylamino, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety or a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

### Claim 21

A method for nucleic acid analysis comprising the steps of
mixing a target nucleic acid with a saturating dsDNA binding dye and an unlabeled probe configured to hybridize to a portion of the target nucleic acid, to form a mixture,
allowing the unlabeled probe to hybridize to the target nucleic acid to form a probe/target duplex,
generating a melting curve for the probe/target duplex by measuring fluorescence from the dsDNA binding dye as the mixture is heated, and
analyzing the shape of the melting curve.

### Claim 22 (depends on 21)

The method of claim 21 wherein the step of analyzing the shape of the melting curve comprises generating a derivative melting curve.

### Claim 23 (depends on 22)

The method of claim 22 wherein the step of analyzing the shape of the melting curve further comprises genotyping by analyzing the shape and location of one or more melting peaks on the derivative melting curve.

### Claim 24 (depends on 21)

The method of claim 21, further comprising the step of
amplifying the target nucleic acid,
wherein the amplifying step takes place before generating the melting curve.

### Claim 25 (depends on 24)

The method of claim 24 wherein the amplifying step includes amplifying by polymerase chain reaction.

### Claim 26 (depends on 25)

The method of claim 25 wherein the polymerase chain reaction is asymmetric polymerase chain reaction.

### Claim 27 (depends on 24)

The method of claim 24 wherein the unlabeled probe is mixed with the target nucleic acid subsequent to amplifying the target nucleic acid.

### Claim 28 (depends on 24)

The method of claim 24 wherein the unlabeled probe and the dsDNA binding dye are added prior to amplifying the target nucleic acid.

### Claim 29 (depends on 28)

The method of claim 28 wherein the unlabeled probe is blocked at the 3′ end to prevent extension during amplification.

### Claim 30 (depends on 21)

The method of claim 21 wherein the unlabeled probe is at least 14 nucleotides long.

### Claim 31 (depends on 21)

The method of claim 21 wherein the mixture includes a second unlabeled probe and the analyzing step includes genotyping at two loci on the target nucleic acid.

### Claim 32 (depends on 21)

The method of claim 21 wherein the mixture includes a second target nucleic acid and a second unlabeled probe configured to hybridize at least partially to the second target nucleic acid, and the analyzing step includes genotyping at a first locus on the target nucleic acid and at a second locus on the second target nucleic acid.

### Claim 33 (depends on 21)

The method of claim 21 wherein the portion of the target nucleic acid comprises a single nucleotide polymorphism.

### Claim 34 (depends on 21)

The method of claim 21 wherein the dsDNA binding dye has a percent saturation of at least 50%.

### Claim 35 (depends on 21)

The method of claim 21 wherein the dye is selected from the group consisting of G5, H5, I5, K5, L5, S5, D6, E6, P6, R6, Y6, Z6, F7, N7, O7, P7, Q7, R7, S7, T7, U7, V7, W7, X7, Z7, C8, E8, G8, K8, L8, M8, N8, O8, P8, T8, V8, W8, X8, Z8, A9, C9, G9, I9, J9, K9, L9, M9, N9, O9, P9, Q9, R9, and A10.

### Claim 36 (depends on 21)

The method of claim 21 wherein the target nucleic acid and the unlabeled probe are free in solution and neither the target nucleic acid nor the unlabeled probe are immobilized on a surface.

### Claim 37

A PCR reaction mixture comprising
a target nucleic acid
PCR reagents,
a pair of oligonucleotide primers configured for amplifying a portion of the target nucleic acid to produce an amplicon, and
a dsDNA binding dye having the formula:
wherein
the moiety Y represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;
X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH3)2 and NR1, where R1 is hydrogen or C1-6 alkyl;
R2 is selected from the group consisting of C1-6 alkyl, C3-8 cycloalkyl, aryl, aryl(C1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;
t=0 or 1;
Z is a charge selected from 0 or 1;
R3, R9, and R10 are each independently selected from the group consisting of hydrogen, C1-6 alkyl, and arylcarbonyl;
n=0, 1, or 2; and
Q is an heterocycle selected from the group of structures consisting of:
wherein R5, R6, R7, and R8 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, arylthio, arylcarbonylthio, dialkylamino, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety or a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety, and
R4 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.

### Claim 38 (depends on 37)

The PCR reaction mixture of claim 37 wherein the dye is selected from the group consisting of F7, N7, O7, P7, Q7, R7, S7, T7, V7, W7, X7, T8, A9, C9, I9, J9, K9, L9, M9, N9, O9, P9 and R9.

### Claim 39 (depends on 37)

The PCR reaction mixture of claim 37 wherein the dsDNA binding dye has a percent saturation of at least 50%.

### Claim 40 (depends on 37)

The PCR reaction mixture of claim 37 further comprising an unlabeled probe configured to hybridize to at least part of the amplicon.

### Claim 41 (depends on 37)

The PCR reaction mixture of claim 37, further comprising a second pair of oligonucleotide primers configured for amplifying a second portion of the target nucleic acid to produce a second amplicon.

### Claim 42

A method of genotyping comprising the steps of
melting a target nucleic acid in the presence of a dsDNA binding dye and an unlabeled probe configured to hybridize at least partially to the target nucleic acid, to generate a melting curve, and
using the melting curve to identify the genotype,
wherein the dsDNA binding dye having the formula:
wherein
the moiety Y represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;
X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH3)2 and NR1, where R1 is hydrogen or C1-6 alkyl;
R2 is selected from the group consisting of C1-6 alkyl, C3-8 cycloalkyl, aryl, aryl(C1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;
t=0 or 1;
Z is a charge selected from 0 or 1;
R3, R9, and R10 are each independently selected from the group consisting of hydrogen, C1-6 alkyl, and arylcarbonyl;
n=0, 1, or 2; and
Q is an heterocycle selected from the group of structures consisting of:
wherein R5, R6, R7, and R8 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, arylthio, arylcarbonylthio, dialkylamino, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety or a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety, and
R4 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.

### Claim 43

A kit for analyzing a target nucleic acid comprising:
an unlabeled probe configured to hybridize at least partially to the target nucleic acid, and
a saturating dsDNA binding dye.

### Claim 44 (depends on 43)

The kit of claim 43, further comprising
a thermostable polymerase, and
oligonucleotide primers configured for amplifying the target nucleic acid.

### Claim 45 (depends on 44)

The kit of claim 44 wherein the oligonucleotide primers comprise a first primer and a second primer, wherein the first primer is provided in a molar amount greater than the second primer.

### Claim 46 (depends on 43)

The kit of claim 43 wherein the unlabeled probe is blocked at the 3′ end.

### Claim 47 (depends on 43)

The kit of claim 43 wherein the dsDNA binding dye has a percent saturation of at least 50%.

### Claim 48 (depends on 43)

The kit of claim 43 wherein the dsDNA binding dye has a percent saturation of at least 90%.

### Claim 49 (depends on 43)

The kit of claim 43 wherein the dye is selected from the group consisting of N7, R7, X7, T8, O7, P8, P7, Q7, T7, V7, W8, Z8, Z7, X8, G9, C9, A9, M9, N9, I9, J9, K9, L9, O9, and P9.

### Claim 50 (depends on 43)

The kit of claim 43 wherein the dye has the formula:
wherein
the moiety Y represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;
X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH3)2 and NR1, where R1 is hydrogen or C1-6 alkyl;
R2 is selected from the group consisting of C1-6 alkyl, C3-8 cycloalkyl, aryl, aryl(C1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;
t=0 or 1;
Z is a charge selected from 0 or 1;
R3, R9, and R10 are each independently selected from the group consisting of hydrogen, C1-6 alkyl, and arylcarbonyl;
n=0, 1, or 2; and
Q is an heterocycle selected from the group of structures consisting of:
wherein R5, R6, R7, and R8 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, alkylthio, arylthio, arylcarbonylthio, dialkylamino, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety or a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety, and
R4 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.

### Claim 51

A method of detecting mutations in the c-kit gene comprising
providing an amplification mixture comprising
a nucleic acid sample,
a pair of primers configured for amplifying a locus of the c-kit gene,
a thermostable polymerase, and
a saturating dsDNA binding dye,
amplifying the nucleic acid sample to generate an amplicon,
melting the amplicon to generate a melting curve, and
analyzing the shape of the melting curve.

### Claim 52 (depends on 51)

The method of claim 51 wherein the analyzing step comprises comparing the shape of the melting curve to the shape of a second melting curve obtained from an analogous wild type amplicon.

### Claim 53 (depends on 51)

The method of claim 51 wherein the pair of primers is selected from the group consisting of GATGCTCTGCTTCTGTACTG (SEQ ID NO. 40) and GCCTAAACATCCCCTTAAATTGG (SEQ ID NO. 41); CTCTCCAGAGTGCTCTAATGAC (SEQ ID NO. 42) and AGCCCCTGTTTCATACTGACC (SEQ ID NO. 43); CGGCCATGACTGTCGCTGTAA (SEQ ID NO. 44) and CTCCAATGGTGCAGGCTCCAA (SEQ ID NO. 45); and TCTCCTCCAACCTAATAGTG (SEQ ID NO. 46) and GGACTGTCAAGCAGAGAAT (SEQ ID NO. 47).

### Claim 54 (depends on 51)

The method of claim 51 wherein the pair of primers has the nucleotide sequences GATGCTCTGCTTCTGTACTG (SEQ ID NO. 40) and GCCTAAACATCCCCTTAAATTGG (SEQ ID NO. 41), and wherein the amplification mixture further comprises additional primers having the sequences CTCTCCAGAGTGCTCTAATGAC (SEQ ID NO. 42), AGCCCCTGTTTCATACTGACC (SEQ ID NO. 43), CGGCCATGACTGTCGCTGTAA (SEQ ID NO. 44), CTCCAATGGTGCAGGCTCCAA (SEQ ID NO. 45), TCTCCTCCAACCTAATAGTG (SEQ ID NO. 46), GGACTGTCAAGCAGAGAAT (SEQ ID NO. 47).

### Claim 55

A method for nucleic acid analysis comprising the steps of
mixing a target nucleic acid with a saturating dsDNA binding dye to form a mixture,
generating a melting curve for the target nucleic acid by measuring fluorescence from the dsDNA binding dye as the mixture is heated,
including in the mixture a second nucleic acid configured to hybridize with a portion of the target nucleic acid, the second nucleic acid being smaller than the target nucleic acid and having a melting temperature different from the target nucleic acid, and allowing the second nucleic acid to hybridize to the portion of the target nucleic acid,
melting the second nucleic acid from the first nucleic acid, and
analyzing the shape of the melting curve.

### Claim 56 (depends on 55)

The method of claim 55 wherein the second nucleic acid is an unlabeled probe and is included in the mixture prior to generating the melting curve.

### Claim 57 (depends on 56)

The method of claim 56, further comprising the step of amplifying the target nucleic acid, wherein the amplifying step occurs subsequent to including the second nucleic acid in the mixture.

### Claim 58 (depends on 56)

The method of claim 56 wherein the target nucleic acid has a Tm and the second nucleic acid has a second Tm, wherein the Tm is higher than the second Tm, and wherein the analyzing step includes analyzing the shape of the melting curve at the Tm and the second Tm.

### Claim 59 (depends on 55)

The method of claim 55 wherein the second nucleic acid is included in the mixture subsequent to generating the melting curve, and the step of melting the second nucleic acid from the first nucleic acid includes generating a second melting curve.

### Claim 60 (depends on 55)

The method of claim 55 wherein the target nucleic acid is amplified by PCR using a first set of primers, the second nucleic acid is amplified by PCR using a second set of primers, and amplification of the target nucleic acid and the second nucleic acid occur in the same reaction mixture.

### Claim 61 (depends on 60)

The method of claim 60 wherein amplification of both the target nucleic acid and the second nucleic acid occurs prior to generating the melting curve.

### Claim 62 (depends on 60)

The method of claim 60 wherein the target nucleic acid is amplified using a first PCR temperature profile and the second nucleic acid is amplified using a second temperature profile.

### Claim 63 (depends on 60)

The method of claim 60 wherein the first set of primers are provided in a ratio for mild asymmetric PCR.

### Claim 64 (depends on 55)

The method of claim 55 wherein the portion of the nucleic acid is known to contain sequence variations.

### Claim 65 (depends on 55)

The method of claim 55 wherein analyzing the shape of the melting curve includes generating a derivative curve and analyzing the shape and location of one or more melting peaks on the derivative melting curve.

### Claim 66

A method of PCR analysis comprising the steps of:
mixing a dsDNA binding dye with a sample comprising an unknown initial quantity of a target nucleic acid and primers configured for amplifying the target nucleic acid, to form a mixture,
amplifying the target nucleic acid in the presence of the dsDNA binding dye,
monitoring fluorescence of the dsDNA binding dye throughout a temperature range during a plurality of amplification cycles, to generate a plurality of melting curves,
using the melting curves to quantify the initial quantity of the target nucleic acid.

### Claim 67 (depends on 66)

The method of claim 66 wherein the mixture further comprises an unlabeled probe configured to hybridize with a portion to the target nucleic acid to form a probe/target duplex, and the temperature range includes the Tm of the probe/target duplex.

### Claim 68 (depends on 67)

The method of claim 67 wherein the using step comprises using a derivative value of the melting curve at a temperature just below the Tm of the probe/target duplex.

### Claim 69 (depends on 67)

The method of claim 67 wherein the using step comprises
generating a derivative melting curve for a specific cycle number, the derivative curve having a melting peak,
determining the melting peak's area, and
using the area to determine initial quantity of the target nucleic acid.

### Claim 70 (depends on 66)

The method of claim 66 wherein the dsDNA binding dye is a saturating dye.
